NTC-121
Discontinued- Indications
- Glioma
Company intelligence / Profile preview
LivaNova
London, England, United Kingdomlivanova.com ↗
- Ownership
- Public · LIVN
- Employees
- ~2900
- Development stage
- Commercial
01
Overview
LivaNova has commercialized multiple medical device products in neuromodulation and cardiopulmonary fields. Its VNS Therapy™ system has treated over 125,000 patients with drug-resistant epilepsy worldwide. The company’s Essenz™ Perfusion System leads its cardiac surgery portfolio. Clinical studies are ongoing for expanded use of its neuromodulation technology in difficult-to-treat depression.
- Therapeutic areas
- PulmonologyPsychiatryNeurologyCardiovascular
- Modalities
- Neuromodulation (Vagus Nerve Stimulation)Medical devices for cardiopulmonary support (heart-lung machines, oxygenators)Implantable devices for sleep apnea and airway obstruction
- Industry
- Therapeutic Medical Devices
02
Drug pipeline
3 assets2 more assets in the full pipeline.
Request access →03
Financials
- Market cap
- $4.4B
- Total revenue
- $390.6M
- Enterprise value
- $4.3B
Beyond the preview
Go deeper on LivaNova.
Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.
Clinical trials
Full profile accessFollow clinical development from trial design and recruitment through results.
- Trial phase
- Status
- Readouts
Licensing & deals
Full profile accessExplore licensing agreements, acquisitions, and the assets behind each deal.
- Partners
- Deal terms
- Milestones
Funding history
Full profile accessTrace financing activity and the investors behind a company’s development.
- Funding rounds
- Investors
- Capital raised
Competitive landscape
Full profile accessCompare peer pipelines by target, modality, and therapeutic area.
- Peer companies
- Targets
- Pipeline overlap
Technologies & patents
Full profile accessExplore technology platforms and the patent landscape around relevant assets.
- Platforms
- Patents
- Assignees
Research & analysis
Full profile accessConnect company news and source material to the questions you’re investigating.
- Company news
- Sources
- Analysis
Bring the full picture into focus.
See how Gosset can support your research on LivaNova.